Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Pharmacoeconomics
|
June 6, 2018
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment
Juan Marcos González, Justin Doan, David J Gebben, et al.
Urologic Oncology
|
July 14, 2007
Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy
Silvia Romero, Gail Stanton, Joseph DeFelice, et al.
European Urology
|
February 7, 2006
Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life?
David Cella, Daniel P Petrylak, Mayer Fishman, et al.
Immunotherapy
|
March 10, 2012
Cellular immunotherapy for soft tissue sarcomas
Steven Eric Finkelstein, Mayer Fishman, Anthony P Conley, et al.
International Journal of Clinical and Experimental Pathology
|
November 3, 2012
The histogenic origin of melanoma arising in respiratory epithelium of a teratomatous germ cell tumor of the mediastinum: an enigma unraveled from an unlikely source
Patricia McNab, Brian Quigley, Tania Mendoza, et al.
Cancer Research
|
November 17, 2007
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova, Mayer Fishman, Simon Sherman, et al.
Journal of Pain and Symptom Management
|
February 19, 2011
Relationship of exercise to quality of life in cancer patients beginning chemotherapy
Leigh Anne Faul, Heather S Jim, Susan Minton, et al.
Cancer Research
|
November 14, 2013
Effects of notch signaling on regulation of myeloid cell differentiation in cancer
Pingyan Cheng, Vinit Kumar, Hao Liu, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer
Yun Yen, Kim Margolin, James Doroshow, et al.
Psycho-Oncology
|
June 14, 2014
Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
Morgan Lee, Heather S Jim, Mayer Fishman, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Pharmacoeconomics
|
June 6, 2018
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment
Juan Marcos González, Justin Doan, David J Gebben, et al.
Urologic Oncology
|
July 14, 2007
Phase II trial of thalidomide and daily oral dexamethasone for treatment of hormone refractory prostate cancer progressing after chemotherapy
Silvia Romero, Gail Stanton, Joseph DeFelice, et al.
European Urology
|
February 7, 2006
Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life?
David Cella, Daniel P Petrylak, Mayer Fishman, et al.
Immunotherapy
|
March 10, 2012
Cellular immunotherapy for soft tissue sarcomas
Steven Eric Finkelstein, Mayer Fishman, Anthony P Conley, et al.
International Journal of Clinical and Experimental Pathology
|
November 3, 2012
The histogenic origin of melanoma arising in respiratory epithelium of a teratomatous germ cell tumor of the mediastinum: an enigma unraveled from an unlikely source
Patricia McNab, Brian Quigley, Tania Mendoza, et al.
Cancer Research
|
November 17, 2007
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova, Mayer Fishman, Simon Sherman, et al.
Journal of Pain and Symptom Management
|
February 19, 2011
Relationship of exercise to quality of life in cancer patients beginning chemotherapy
Leigh Anne Faul, Heather S Jim, Susan Minton, et al.
Cancer Research
|
November 14, 2013
Effects of notch signaling on regulation of myeloid cell differentiation in cancer
Pingyan Cheng, Vinit Kumar, Hao Liu, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer
Yun Yen, Kim Margolin, James Doroshow, et al.
Psycho-Oncology
|
June 14, 2014
Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
Morgan Lee, Heather S Jim, Mayer Fishman, et al.
Page
of 7